Marcia Brose
马西娅·布罗斯
MD, PhD
Professor of Otolaryngology and Medical Oncology耳鼻喉科及肿瘤内科学教授
👥Biography 个人简介
Internationally recognized thyroid cancer specialist who led the landmark DECISION trial of sorafenib in radioiodine-refractory differentiated thyroid cancer. Expert in RET inhibitors and molecular-targeted therapy for advanced thyroid malignancies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
DECISION Trial
Principal investigator of the DECISION trial demonstrating sorafenib's efficacy in radioiodine-refractory differentiated thyroid cancer, leading to FDA approval and establishing a new treatment paradigm.
Representative Works 代表性著作
Sorafenib in radioiodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial (DECISION)
The Lancet (2014)
Definitive phase 3 trial establishing sorafenib as standard of care for advanced RAI-refractory differentiated thyroid cancer.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 马西娅·布罗斯 的研究动态
Follow Marcia Brose's research updates
留下邮箱，当我们发布与 Marcia Brose（Thomas Jefferson University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment